You know you need to reach mobile consumers, but you also know its really tough to get attention on smartphones and tablets. Now imagine you could predict which moments your audience was most likely to respond to your mobile ads? That’s what Aki Technologies does—Aki’s AI-powered moment marketing science uncovers patterns in ad receptivity so you can deliver more timely and relevant mobile advertising. By reaching consumers in the optimal mobile moments—with the optimal message—Aki eliminates friction and improves mobile ad metrics like awareness, engagement, foot traffic and sales. Get the details at [email protected].
We are the independent digital agency that explores the boundaries of the possible and never compromises on quality. Never.
We optimize the strategy and implementation of multichannel digital campaigns that support late-stage development and the launch of innovative therapies. How? By catalyzing AORs and healthcare brands to think differently about digital campaigns, and enhancing implementation by corporate IT.
We solve business problems with technology — SEO, SEM, CRM, websites, mobile apps and web applications. Arteric blends extraordinary software development expertise, analytics and marketing insights to transform AOR strategy into defect-free tactics that deliver multiyear competitive advantage.
Avant Healthcare is a medical and marketing communications agency that strategically partners with pharmaceutical and biotechnology clients to engage and educate healthcare providers. By reshaping medical education, Avant Healthcare helps change the beliefs of healthcare provider audiences.
Avant Healthcare’s Medical Affairs Center of Excellence is specifically designed and reserved for solving the unique challenges of Medical Affairs. Our breadth of experience and methodology behind scientific insight, analysis, and innovation mobilizes and supports the expanding value of your Medical Affairs organization.
BioPharm Communications is the leading provider of data-driven, fully integrated multichannel marketing services to the pharmaceutical and biotech industries through its unique capabilities and assets. BioPharm is the multichannel marketing division of Omnicom Health Group, the largest global healthcare communications organization.
BioPharm is actively working with 50+ pharma and biotech companies and has delivered multichannel campaigns for 200+ brands. BioPharm’s proprietary database contains unparalleled behavioral data for more than 1.1 million high-profile US HCPs based on data from over 1,000 BioPharm campaigns. This database is the foundation of BioPharm’s data-driven approach to campaign planning, development, and deployment.
Crossix partners with top health brands to maximize media and marketing effectiveness through robust data analytics. Fueled by our privacy-by-design, patented Crossix SafeMine™ technology, Crossix connects the industry’s most comprehensive set of health and non-health data, covering more than 300 million lives in the United States. Crossix DIFA™, our best-in-class, cloud-based platform, allows real-time measurement and optimization of complex, cross-channel media campaigns aimed at patients and healthcare professionals.
Customers include more than 200 pharmaceutical brands across the top 20 pharma companies, leading health systems, pharmacies, and other wellness brands. Crossix is an independent business unit of Veeva Systems and is headquartered in New York.
DeepIntent is a marketing technology company that helps healthcare brands strengthen communication with patients and healthcare professionals by enabling highly effective and performant digital advertising campaigns. Our healthcare technology platform, MarketMatch™, connects advertisers, data providers, and publishers to operate the first unified, programmatic marketplace for healthcare marketers. The platform’s built-in identity solution matches digital IDs with clinical, behavioral, and contextual data in real-time so marketers can qualify 1.6M+ verified HCPs and 225M+ patients to find their most clinically-relevant audiences, and message them on a one-to-one basis in a privacy compliant way. DeepIntent was founded by Memorial Sloan Kettering alumni in 2015 and acquired by Propel Media, Inc. in 2017. We proudly serve major pharmaceutical and Fortune 500 companies out of our offices in New York, California, and India.
Doximity is the largest, fastest-growing HCP network in the U.S., with more than 2/3 of all U.S. physicians as active members. Physicians across all specialties use Doximity to exchange HIPAA-secure messages, collaborate on patient cases, and read clinically relevant content in a custom DocNews feed.
A variety of physician engagement opportunities are available to partners, including sponsored scientific DocNews alerts and custom data insights. Doximity has also partnered with Amion, the largest physician hospital scheduling platform in the U.S., facilitating the publication of clinical content on the Amion mobile app. This enables brands to target hard-to-reach hospital-based physicians within a workflow tool they check daily.
Figure 1 is a mobile platform where global healthcare professionals share medical cases in order to improve patient outcomes. Figure 1 has worked with close to 30 pharmaceutical companies on educational campaigns that have educated more than 250K HCPs globally. Last year, along with BioMarin, Figure 1 won the Most Valuable Healthcare/HCP Initiative at the eyeforpharma awards.
Healthlink Dimensions is the pioneer and leading vendor of integrated provider data, enterprise-level data management, and messaging outreach for healthcare marketers, recruiters, and coordinators. Our services empower customers to engage healthcare providers and professionals directly and successfully, building the ongoing connections that lead to community. Comprehensive, accurate data and flexible omnichannel services ensure optimized outreach, enabling organizations to focus on building relationships rather than data hygiene and maintenance. Our scalable offerings transparently support in-house capabilities, delivering outstanding value. Above all, our deep understanding of healthcare marketing enables us to help each client solve unique challenges to build successful relationships with key healthcare providers and professionals.
HealthPrize, the leading provider of patient engagement, education and adherence technology for life science companies, enables pharmaceutical brands to develop branded adherence programs configured to the unique requirements and challenges of a specific medication or therapeutic area. We use gamification, behavioral economics and loyalty marketing best practices to address the leading behavioral causes for medication nonadherence.
Health Union makes participating in the patient journey effortless for industry partners. Every day, Health Union encourages social interactions that evolve into valuable online health conversations, helping people with chronic conditions find the information, connection and validation they seek. Simultaneously, these efforts advance the knowledge of biopharmaceutical partners, delivering valuable solutions that make consumer-focused marketing programs smarter and more effective. Today, Health Union owns and operates 19 open, online health communities, including LungCancer.net, MultipleSclerosis.net and Type2Diabetes.com.
MedData Group is the leader in HCP data solutions for fueling multi-channel digital campaigns providing digital targeting (programmatic), email and offline data to identify and surround your target audience. Partnering with ad agencies, pharmaceuticals, medical device, biopharmaceuticals, publishers, recruiters, medical education and medical technology providers, our suite of data solutions helps marketers reach and engage the right HCP audiences through the right digital channels. With a database of over 3.5 million HCPs, MedData Group’s data supports HCP targeting at scale. Our extensive database allows for highly deterministic targeting by digital, social, and mobile IDs, as well as email and dozens of other demographic, organizational and professional data points. Customers can also leverage our comprehensive Rx (prescribing), Dx (diagnosis) and Px (procedures) clinical indicator database for behavioral segmentation and enhancing campaign targeting and analysis. Providing fuel for promotions no matter the digital channel, we look forward to discussing your specific needs. Please stop by our booth and/or visit us at www.meddatagroup.com
OptimizeRx® (NASDAQ: OPRX), a digital health company, connects pharmaceutical companies to patients and providers, offering greater affordability, adherence and brand awareness at the point-of-care. As the nation’s largest point-of-prescribe promotional platform for the pharmaceutical industry, OptimizeRx provides a direct channel for pharma companies to communicate with healthcare providers right within their workflow. The cloud-based solution supports patient adherence to medications with real-time access to financial assistance, prior authorization, education and critical clinical information. OptimizeRx provides more than half of the ambulatory patient market with access to these benefits through leading EHR platforms like Allscripts, Amazing Charts and Quest. The company’s mobile messaging platform, formerly CareSpeak Communications, also supports direct, real-time communication to patients for improved medication adherence, affordability, and healthcare outcomes. For more information, follow the company on Twitter, LinkedIn or visit .
PatientPoint® connects pharmaceutical and health and wellness brands to their most valuable patients and physicians at critical decision-making moments. Harnessing the power of digital and mobile technology, our comprehensive platform of patient engagement solutions features award-winning health education that drives doctor-patient discussions and positions your brand as the solution. For 30 years, clients have trusted PatientPoint to provide a category-exclusive approach to owning the office that delivers direct revenue—guaranteed. By the end of 2018, PatientPoint programs are on track to reach more than 140,000 HCPs in 51,000 physician offices and 1,000 hospitals nationwide. Learn more at patientpoint.com.
Prognos Health is an AI platform company focused on predicting the trajectory of disease to drive decisions earlier in healthcare in collaboration with payers, life sciences and providers. The Prognos Registry is the largest source of clinical diagnostics information in 50 disease areas, with nearly billions of medical records for hundreds of millions of patients. Prognos has over 1,000 extensive proprietary and learning clinical algorithms to enable earlier patient identification for enhanced treatment decision-making, risk management and quality improvement. The company’s investors include Safeguard Scientifics, Inc., Merck Global Health Innovation Fund, Cigna, GIS Strategic Ventures, Hikma Ventures, Hermed Capital, and Maywic Select Investments. Learn more about Prognos at www.prognoshealth.com
Sermo is a global social platform for physicians that fosters impactful peer-to-peer collaboration & discussions through meaningful insights, data, and trends. It is the most trusted global platform for physicians with over 800,000 fully verified and licensed physicians across 150 countries. The platform enables doctors to anonymously talk real-world medicine, review treatment options via our proprietary Drug Ratings platform, collectively solve patient cases, and earn honorarium from surveys. Through Sermo’s unique community, pharmaceutical and healthcare partners can drive physician awareness and gain deep understanding of brand perceptions to benefit the medical community at large. For more information, please visit www.sermo.com/business
Swoop provides best-in-class health segments for audience targeting. By modeling populations based on deidentified health and demographic data, Swoop is able to provide biopharma clients with unique custom audiences designed to meet your exact commercial goals. As the first and only consumer health data oriented member of the NAI, Swoop is uniquely positioned to guarantee to clients that their targeting segments are completely compliant with the NAI's health-related ad targeting guidance.
TI Health is an intelligent data-driven marketing company serving leading pharmaceutical and healthcare marketers, working in partnership to improve targeting and delivering superior return on their marketing investment. The company has developed products that respond to event triggers and signals in the healthcare marketplace, with the ability to serve targeted messaging to professionals and consumers digitally. TI Health can deploy advertisements specifically to the handheld devices of healthcare professionals when they are in the vicinity of a practice or point of care location, in response to highly targeted and timely data feeds such as diagnostics, labs, claims and fluctuations within formulary access.